ERFSF OTC
Eurofins Scientific SE
1W: -4.4%
1M: +0.2%
3M: +6.7%
YTD: +15.4%
1Y: +19.6%
3Y: +53.7%
5Y: -33.4%
$85.95
+3.43 (+4.16%)
Weekly Expected Move ±6.5%
$75
$80
$86
$91
$97
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$11.0B
+0.8% ▲
5Y CAGR: +5.1%
Total Liabilities
$7.4B
+34.4% ▲
5Y CAGR: +8.8%
Shareholders Equity
$3.5B
-33.7% ▼
5Y CAGR: -0.8%
Cash & Investments
$791M
+28.8% ▲
5Y CAGR: -2.8%
Total Debt
$5.4B
+50.4% ▲
5Y CAGR: +11.5%
Net Debt
$4.6B
+54.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $515M | $487M | $1.2B | $614M | $791M |
| Short-Term Investments | $0 | $54M | $4M | $0 | $0 |
| Cash & ST Investments | $515M | $492M | $1.2B | $614M | $791M |
| Net Receivables | $1.4B | $1.3B | $1.4B | $1.5B | $1.5B |
| Inventory | $154M | $146M | $139M | $142M | $139M |
| Other Current Assets | $192M | $256M | $236M | $104M | $186M |
| Total Current Assets | $2.3B | $2.3B | $3.1B | $2.5B | $2.7B |
| Property, Plant & Equip. | $1.8B | $2.2B | $2.3B | $2.6B | $2.8B |
| Goodwill & Intangibles | $5.0B | $5.4B | $5.3B | $5.6B | $5.3B |
| Long-Term Investments | $82M | $84M | $84M | $117M | $105M |
| Other Non-Current Assets | $0 | $100K | $94M | $0 | $1000K |
| Total Non-Current Assets | $7.0B | $7.8B | $7.8B | $8.4B | $8.3B |
| Total Assets | $9.3B | $10.1B | $10.9B | $10.9B | $11.0B |
| — Liabilities — | |||||
| Accounts Payable | $323M | $347M | $339M | $646M | $678M |
| Short-Term Debt | $133M | $85M | $458M | $329M | $727M |
| Deferred Revenue | $974M | $184M | $0 | $0 | $217M |
| Other Current Liabilities | -$556M | $191M | $358M | $229M | $778M |
| Total Current Liabilities | $1.9B | $1.8B | $2.1B | $2.1B | $2.4B |
| Long-Term Debt | $2.1B | $2.7B | $2.9B | $2.7B | $4.7B |
| Other Non-Current Liab. | $0 | $215M | $194M | $152M | $143M |
| Total Non-Current Liabilities | $2.8B | $3.5B | $3.6B | $3.4B | $5.0B |
| Total Liabilities | $4.7B | $5.2B | $5.8B | $5.5B | $7.4B |
| — Equity — | |||||
| Common Stock | $2M | $2M | $2M | $2M | $2M |
| Retained Earnings | $2.0B | $2.3B | $2.4B | $2.7B | $3.0B |
| Accumulated OCI | $2.7B | $2.5B | $2.7B | $3.0B | -$247M |
| Total Stockholders Equity | $4.6B | $4.8B | $5.1B | $5.3B | $3.5B |
| Total Liabilities & Equity | $9.3B | $10.1B | $10.9B | $10.9B | $11.0B |
| — Key Metrics — | |||||
| Total Debt | $2.8B | $3.3B | $3.9B | $3.6B | $5.4B |
| Net Debt | $2.2B | $2.8B | $2.7B | $3.0B | $4.6B |
| Total Investments | $82M | $138M | $88M | $117M | $105M |